| Identification | Back Directory | [Name]
L-Aspartic acid, glycyl-L-leucyl-L-lysylglycyl-L-prolyl-L-α-aspartyl-L-isoleucyl-L-tyrosyl-L-lysylglycyl-L-valyl-L-tyrosyl-L-glutaminyl-L-phenylalanyl-L-lysyl-L-seryl-L-valyl-L-α-glutamyl-L-phenylalanyl- | [CAS]
232598-19-5 | [Synonyms]
L-Aspartic acid, glycyl-L-leucyl-L-lysylglycyl-L-prolyl-L-α-aspartyl-L-isoleucyl-L-tyrosyl-L-lysylglycyl-L-valyl-L-tyrosyl-L-glutaminyl-L-phenylalanyl-L-lysyl-L-seryl-L-valyl-L-α-glutamyl-L-phenylalanyl- | [Molecular Formula]
C108H160N24O31 | [MOL File]
232598-19-5.mol | [Molecular Weight]
2290.57 |
| Chemical Properties | Back Directory | [Boiling point ]
2312.2±65.0 °C(Predicted) | [density ]
1.312±0.06 g/cm3(Predicted) | [form ]
Solid | [color ]
White to off-white | [Sequence]
Gly-Leu-Lys-Gly-Pro-Asp-Ile-Tyr-Lys-Gly-Val-Tyr-Gln-Phe-Lys-Ser-Val-Glu-Phe-Asp |
| Hazard Information | Back Directory | [Uses]
LCMV GP (61-80) is a peptide fragment derived from lymphocytic choriomeningitis virus (LCMV) glycoprotein (GP), and corresponds to amino acids 61-80. LCMV GP (61-80) is a specific epitope which can induce CD4+ T-cell response[1][2][3]. | [References]
[1] Rodriguez F, et, al. CD4(+) T cells induced by a DNA vaccine: immunological consequences of epitope-specific lysosomal targeting. J Virol. 2001 Nov; 75(21): 10421-30. DOI:10.1128/JVI.75.21.10421-10430.2001
[2] Andargachew R, et, al. CD4 T Cell Affinity Diversity Is Equally Maintained during Acute and Chronic Infection. J Immunol. 2018 Jul 1; 201(1):19-30. DOI:10.4049/jimmunol.1800295
[3] Homann D, et, al. Mapping and restriction of a dominant viral CD4+ T cell core epitope by both MHC class I and MHC class II. Virology. 2007 Jun 20; 363(1): 113-23. DOI:10.1016/j.virol.2006.12.025 |
|
| Company Name: |
Fuan Bio
|
| Tel: |
15002819872 |
| Website: |
|
| Company Name: |
MedChemExpress
|
| Tel: |
021-58955995 |
| Website: |
www.medchemexpress.com |
|